What is the most recent earnings date for LUNG stock?
PULMONX CORP (LUNG) last reported earnings on 4/29/2026.
PULMONX CORP (LUNG) Earnings History & Surprises
NASDAQ:LUNG • US7458481014
Current stock price
1.275 USD
+0.07 (+6.25%)
Last:
LUNG Earnings overview
Past quarterly earnings results for PULMONX CORP (LUNG), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q2 / 2026
- EPS Estimate
- -$0.28
- Revenue Estimate
- 22.866M
Last Reported
Most Recent- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Reported
- -$0.33
- EPS Surprise
- 0.96%
- Revenue Surprise
- -1.20%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | -0.33 | -0.33 | 0.96% | 8.33% | 20.59M | 20.841M | -1.20% | -8.64% |
| Q4 2025 | -0.25 | -0.40 | 37.47% | 24.24% | 22.598M | 22.163M | 1.96% | -4.91% |
| Q3 2025 | -0.34 | -0.43 | 20.32% | 5.56% | 21.502M | 21.286M | 1.01% | 5.47% |
| Q2 2025 | -0.38 | -0.38 | 0.21% | -8.57% | 23.859M | 23.938M | -0.33% | 14.80% |
| Q1 2025 | -0.36 | -0.38 | 5.30% | - | 22.538M | 22.474M | 0.28% | 19.54% |
| Q4 2024 | -0.33 | -0.46 | 27.70% | 8.33% | 23.765M | 22.736M | 4.53% | 23.28% |
| Q3 2024 | -0.36 | -0.46 | 21.31% | 7.69% | 20.387M | 20.694M | -1.48% | 15.39% |
| Q2 2024 | -0.35 | -0.43 | 19.29% | 18.60% | 20.783M | 20.536M | 1.20% | 20.87% |
| Q1 2024 | -0.36 | -0.47 | 23.51% | 14.29% | 18.854M | 18.251M | 3.30% | 29.71% |
| Q4 2023 | -0.36 | -0.42 | 13.32% | 5.26% | 19.278M | 18.639M | 3.43% | 24.94% |
| Q3 2023 | -0.39 | -0.44 | 10.63% | -2.63% | 17.668M | 16.714M | 5.71% | 30.87% |
| Q2 2023 | -0.43 | -0.45 | 3.49% | -7.50% | 17.194M | 16.178M | 6.28% | 23.25% |
| Q1 2023 | -0.42 | -0.45 | 6.42% | 2.33% | 14.535M | 13.764M | 5.60% | 34.71% |
| Q4 2022 | -0.38 | -0.42 | 10.51% | -8.57% | 15.43M | 14.263M | 8.18% | 12.55% |
| Q3 2022 | -0.38 | -0.40 | 6.06% | -35.71% | 13.5M | 15.215M | -11.27% | 1.81% |
| Q2 2022 | -0.40 | -0.42 | 4.32% | -17.65% | 13.95M | 14.003M | -0.38% | 14.34% |
| Q1 2022 | -0.43 | -0.38 | -13.59% | -26.47% | 10.79M | 9.446M | 14.23% | 16.77% |
| Q4 2021 | -0.35 | -0.37 | 4.77% | -29.63% | 13.71M | 14.527M | -5.62% | 39.47% |
| Q3 2021 | -0.28 | -0.38 | 26.23% | 87.61% | 13.26M | 13.441M | -1.35% | 24.98% |
| Q2 2021 | -0.34 | -0.38 | 10.36% | - | 12.2M | 10.718M | 13.83% | 232.43% |
| Q1 2021 | -0.34 | -0.39 | 11.88% | - | 9.24M | 8.3M | 11.33% | 7.19% |
| Q4 2020 | -0.27 | -0.28 | 4.78% | - | 9.83M | 8.984M | 9.42% | - |
| Q3 2020 | -2.26 | -4.41 | 48.71% | - | 10.61M | 8.534M | 24.33% | - |
| Q2 2020 | - | - | 3.67M | - | - | |||
| Q1 2020 | - | - | 8.62M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
15.83%
Max EPS beat (4)
37.48%
Min EPS beat (4)
0.21%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
0.73%
Max Revenue beat (4)
1.96%
Min Revenue beat (4)
-0.33%
Analysis
In the last 4 quarters, LUNG has consistently beaten EPS estimates in all releases
LUNG has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, LUNG has beaten the EPS estimates by 15.8% on average.
In the last 4 quarters, LUNG has beaten the revenue estimates by 0.7% on average.
Related analysis
PULMONX CORP / LUNG Earnings FAQ
Can you provide information on whether PULMONX CORP beat earnings estimates in the last quarter?
PULMONX CORP (LUNG) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does PULMONX CORP (LUNG) beat earnings estimates?
In the last 4 quarters, PULMONX CORP (LUNG) has beaten EPS estimates in 4 out of 4 releases.